New insights and clinical advancements in cellular oncology

Cellular Oncology

Volumn 35, Issue 3, 2012, Pages 139-147

  Van Kessel, Ad Geurts ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ARTICLE; CANCER DIAGNOSIS; CANCER GENETICS; CANCER PROGNOSIS; CANCER RISK; CANCER STEM CELL; CANCER THERAPY; CELL AGING; CHROMOSOMAL INSTABILITY; CHROMOSOME TRANSLOCATION; CYTOGENETICS; EPIGENETICS; HUMAN; LEUKEMIA; PRIORITY JOURNAL; SOLID TUMOR; TUMOR MICROENVIRONMENT;

ANIMALS; CELL AGING; CHROMOSOMAL INSTABILITY; CHROMOSOME FRAGILE SITES; EPIGENESIS, GENETIC; HUMANS; MEDICAL ONCOLOGY; MICE; MOLECULAR TARGETED THERAPY; NEOPLASMS; NEOPLASTIC STEM CELLS; PROTO-ONCOGENE PROTEINS C-MYC; RISK FACTORS; TRANSLOCATION, GENETIC; TUMOR MICROENVIRONMENT;

EID: 84870019602     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-012-0083-7     Document Type: Article

References (47)

1. N.M. Sodir, G.I. Evan, Finding cancer's weakest link. Oncotarget 2, 1307-1313 (2011)
2. R. Brough, J.R. Frankum, S. Costa-Cabral, C.J. Lord, A. Ashworth, Searching for synthetic lethality in cancer. Curr. Opin. Genet. Dev. 21, 34-41 (2011)
3. J.D. Kessler, K.T. Kahle, T. Sun, K.L. Meerbrey, M.R. Schlabach, E.M. Schmitt, S.O. Skinner, Q. Xu, M.Z. Li, Z.C. Hartman, M. Rao, P. Yu, R. Dominguez-Vidana, A.C. Liang, N.L. Solimini, R.J. Bernardi, B. Yu, T. Hsu, I. Golding, J. Luo, C.K. Osborne, C.J. Creighton, S.G. Hilsenbeck, R. Schiff, C.A. Shaw, S.J. Elledge, T.F. Westbrook, A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis. Science 335, 348-353 (2012)
4. G. Evan, Taking a backdoor to target Myc. Science 335, 293-294 (2012)
5. C. Michaloglou, L.C. Vredeveld, M.S. Soengas, C. Denoyelle, T. Kuilman, C.M. van der Horst, D.M. Majoor, J.W. Shay,W.J. Mooi, D.S. Peeper, BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436, 720-724 (2005) (Pubitemid 41117276)
6. T.W. Kang, T. Yevsa, N. Woller, L. Hoenicke, T. Wuestefeld, D. Dauch, A. Hohmeyer, M. Gereke, R. Rudalska, A. Potapova, M. Iken, M. Vucur, S. Weiss, M. Heikenwalder, S. Khan, J. Gil, D. Bruder, M. Manns, P. Schirmacher, F. Tacke, M. Ott, T. Luedde, T. Longerich, S. Kubicka, L. Zender, Senescence surveillance of premalignant hepatocytes limits liver cancer development. Nature 479, 547-551 (2011)
7. M. Serrano, Final act of senescence. Nature 479, 481-482 (2011)
8. H. Li, M. Collado, A. Villasante, K. Strati, S. Ortega, M. Cañamero, M.A. Blasco, M. Serrano, The Ink4/Arf locus is a barrier for iPS cell programming. Nature 460, 1136-1139 (2009)
9. S. Menendez, S. Camus, A. Herreria, I. Paramonov, L.B. Morera, M. Collado, V. Pekarik, I. Maceda, M. Edel, A. Consiglio, A. Sanchez, H. Li, M. Serrano, J.C. Belmonte, Increased dosage of tumor suppressors limits the tumorigenicity of iPS cells without affecting their pluripotency. Aging Cell 11, 41-50 (2012)
10. D. Pérez-Martínez, T. Tanaka, T.H. Rabbitts, Intracellular antibodies and cancer: new technologies offer therapeutic opportunities. Bioassays 32, 589-598 (2010)
11. P. Vigneri, J.Y.Wang, Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase. Nat. Med. 7, 228-234 (2001) (Pubitemid 32148491)
12. A.S. Dixon, J.E. Constance, T. Tanaka, T.H. Rabbitts, C.S. Lim, Changing the subcellular location of the oncoprotein bcr-abl using rationally designed capture motifs. Pharm. Res. 29, 1098-1109 (2012)
13. S.A. Tomlins, D.R. Rhodes, S. Perner, S.M. Dhanasekaran, R. Mehra, X.W. Sun, S. Varambally, X. Cao, J. Tchinda, R. Kuefer, C. Lee, J.E. Montie, R.B. Shah, K.J. Pienta, M.A. Rubin, A.M. Chinnaiyan, Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310, 644-648 (2005) (Pubitemid 41528150)
14. P.A. Edwards, K.D. Howarth, Are breast cancers driven by fusion genes? Breast Cancer Res. 14, 303 (2012)
15. D.R. Robinson, S. Kalyana-Sundaram, Y.M. Wu, S. Shankar, X. Cao, B. Ateeq, I.A. Asangani, M. Iyer, C.A. Maher, C.S. Grasso, R.J. Lonigro, M. Quist, J. Siddiqui, R. Mehra, X. Jing, T.J. Giordano, M.S. Sabel, C.G. Kleer, N. Palanisamy, R. Natrajan, M.B. Lambros, J.S. Reis-Filho, C. Kumar-Sinha, A.M. Chinnaiyan, Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer. Nat. Med. 17, 1646-1651 (2011)
16. A. Letessier, G.A. Millot, S. Koundrioukoff, A.M. Lachagès, N. Vogt, R.S. Hansen, B. Malfoy, O. Brison, M. Debatisse, Cell-typespecific replication initiation programs set fragility of the FRA3B fragile site. Nature 470, 120-123 (2011)
17. B. Le Tallec, B. Dutrillaux, A.M. Lachages, G.A. Millot, O. Brison, M. Debatisse, Molecular profiling of common fragile sites in human fibroblasts. Nat. Struct. Mol. Biol. 18, 1421-1423 (2011)
18. M. Debatisse, B. Le Tallec, A. Letessier, B. Dutrillaux, O. Brison, Common fragile sites: mechanisms of instability revisited. Trends Genet. 28, 22-32 (2012)
19. S.F. Bakhoum, S.L. Thompson, A.L. Manning, D.A. Compton, Genome stability is ensured by temporal control of kinetochoremicrotubule dynamics. Nat. Cell. Biol. 11, 27-35 (2009)
20. L. Kabeche, D.A. Compton, Checkpoint-independent stabilization of kinetochore-microtubule attachments by Mad2 in human cells. Curr. Biol. [Epub ahead of print] (2012)
21. R. de Voer, N. Hoogerbrugge, R.P. Kuiper, Spindle-assembly checkpoint and gastrointestinal cancer. New Eng. J. Med. 364, 1279-1280 (2010)
22. A. Janssen, M. van der Burg, K. Szuhai, G.J.P.L. Kops, R. Medema, Chromosome segregation errors as a cause of DNA damage and structural chromosome aberrations. Science 333, 1895-1898 (2011)
23. A. Geurts van Kessel, The 'omics' of cancer. Cancer Genet. Cytogenet. 203, 37-42 (2010)
24. C.K. Ng, S.L. Cooke, K. Howe, S. Newman, J. Xian, J. Temple, E.M. Batty, J.C. Pole, S.P. Langdon, P.A. Edwards, J.D. Brenton, The role of tandem duplicator phenotype in tumour evolution in high-grade serous ovarian cancer. J. Pathol. 226, 703-712 (2012)
25. J.J. Molenaar, J. Koster, D.A. Zwijnenburg, P. van Sluis, L.J. Valentijn, I. van der Ploeg, M. Hamdi, J. van Nes, B.A. Westerman, J. van Arkel, M.E. Ebus, F. Haneveld, A. Lakeman, L. Schild, P. Molenaar, P. Stroeken, M.M. van Noesel, I. Ora, E.E. Santo, H.N. Caron, E.M. Westerhout, R. Versteeg, Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature 483, 589-593 (2012)
26. I.P. Tomlinson, R.S. Houlston, G.W. Montgomery, O.M. Sieber, M.G. Dunlop, Investigation of the effects of DNA repair gene polymorphisms on the risk of colorectal cancer. Mutagenesis 27, 219-223 (2012)
27. R.S. Houlston, members of COGENT. COGENT (COlorectal cancer GENeTics) revisited. Mutagenesis 27, 143-151 (2012)
28. R.R. Laborde, V.W. Wang, T.M. Smith, N.E. Olson, S.M. Olsen, J.J. García, K.D. Olsen, E.J. Moore, J.L. Kasperbauer, N.M. Tombers, D.I. Smith, Transcription profiling by sequencing of oropharyngeal cancer. Mayo Clinic Proc. 87, 226-232 (2012)
29. T. Li, J. Chien, D.I. Smith, J. Ma, Fusion hunter: identifying transcripts in cancer using paired-end RNA-seq. Bioinformatics 27, 1708-1710 (2011)
30. I.B. Weinstein, Addiction to oncogenes -the achilles heal of cancer. Science 297, 63-64 (2002) (Pubitemid 34743088)
31. D.W. Felsher, MYC inactivation elicits oncogene addiction through both tumor cell-intrinsic and host-dependent mechanisms. Genes Cancer 1, 597-604 (2010)
32. P.T. Tran, P.K. Bendapudi, H.J. Lin, P. Choi, S. Koh, J. Chen, G. Horng, N.P. Hughes, L.H. Schwartz, V.A. Miller, T. Kawashima, T. Kitamura, D. Paik, D.W. Felsher, Survival and death signals can predict tumor response to therapy after oncogene activation. Sci. Transl. Med. 3, 103ra99 (2011)
33. R. Kirk, Immunotherapy: a first for first-line therapy in NSCLC. Nat. Rev. Clin. Oncol. 8, 691 (2011)
34. B. Beck, C. Blanpain, Mechanisms regulating epidermal stem cells. EMBO J. [Epub ahead of print] (2012)
35. B. Gan, J. Hu, S. Jiang, Y. Liu, E. Sahin, L. Zhuang, E. Fletcher-Sananikone, S. Colla, Y.A. Wang, L. Chin, R.A. Depinho, Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells. Nature 468, 701-704 (2010)
36. I. Malanchi, A. Santamaria-Martínez, E. Susanto, H. Peng, H.A. Lehr, J.F. Delaloye, J. Huelsken, Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 481, 85-89 (2012)
37. T.J. Perren, A.M. Swart, J. Pfisterer, J.A. Ledermann, E. Pujade-Lauraine, G. Kristensen, M.S. Carey, P. Beale, A. Cervantes, C. Kurzeder, A. du Bois, J. Sehouli, R. Kimmig, A. Stähle, F. Collinson, S. Essapen, C. Gourley, A. Lortholary, F. Selle, M.R. Mirza, A. Leminen, M. Plante, D. Stark, W. Qian, M.K. Parmar, A.M. Oza, ICON7 Investigators. A phase 3 trial of bevacizumab in ovarian cancer. New Eng. J. Med. 365, 1484-2496 (2011)
38. V.P. Chauhan, Z. Popovic, O. Chen, J. Cui, D. Fukumura, M.G. Bawendi, R.K. Jain, Fluorescent nanorods and nanospheres for real-time in vivo probing of nanoparticle shape-dependent tumor penetration. Angew. Chem. Int. Ed. 50, 11417-11420 (2011)
39. J.R. van Beijnum, P. Nowak-Sliwinska, E. van den Boezem, P. Hautvast, W.A. Buurman, A.W. Griffioen. Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1. Oncogene [Epub ahead of print] (2012)
40. E. Kluza, I. Jacobs, S.J. Hectors, K.H. Mayo, A.W. Griffioen, G.J. Strijkers, K. Nicolay, Dual-targeting of avß3 and galectin-1 improves the specificity of paramagnetic/fluorescent liposomes to tumor endothelium in vivo. J. Contr. Release 158, 207-214 (2012)
41. J.R. van Beijnum, R.P. Dings, E. van der Linden, B.M. Zwaans, F.C. Ramaekers, K.H. Mayo, A.W. Griffioen, Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculature. Blood 108, 2339-2348 (2006) (Pubitemid 44497518)
42. A. Weiss, H.V. den Bergh, A.W. Griffioen, P. Nowak-Sliwinska, Angiogenesis inhibition for the improvement of photodynamic therapy: the revival of a promising idea. Biochim. Biophys. Acta. 1826, 53-70 (2012)
43. M. Esteller, M.F. Fraga, M.F. Paz, E. Campo, D. Colomer, F.J. Novo, M.J. Calasanz, O. Ga, M. Guo, J. Benitez, J.G. Herman, Cancer epigenetics and methylation. Science 297, 1807-1808 (2002)
44. S.M. Langemeijer, R.P. Kuiper, M. Berends, R. Knops, M.G. Aslanyan, M. Massop, E. Stevens-Linders, P. van Hoogen, A. Geurts van Kessel, R.A. Raymakers, E.J. Kamping, G.E. Verhoef, E. Verburgh, A. Hagemeijer, P. Vandenberghe, T. de Witte, B.A. van der Reijden, J.H. Jansen, Acquired mutations in TET2 are common in myelodysplastic syndromes. Nat. Genet. 41, 838-842 (2009)
45. G. Nikoloski, S.M. Langemeijer, R.P. Kuiper, R. Knops, M. Massop, E.R. Tönnissen, A. van der Heijden, T.N. Scheele, P. Vandenberghe, T. de Witte, B.A. van der Reijden, J.H. Jansen, Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes. Nat. Genet. 42, 665-667 (2010)
46. J.P. Patel, M. Gönen, M.E. Figueroa, H. Fernandez, Z. Sun, J. Racevskis, P. Van Vlierberghe, I. Dolgalev, S. Thomas, O. Aminova, K. Huberman, J. Cheng, A. Viale, N.D. Socci, A. Heguy, A. Cherry, G. Vance, R.R. Higgins, R.P. Ketterling, R.E. Gallagher, M. Litzow, M.R. van den Brink, H.M. Lazarus, J.M. Rowe, S. Luger, A. Ferrando, E. Paietta, M.S. Tallman, A. Melnick, O. Abdel-Wahab, R.L. Levine, Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. New Engl. J. Med. 366, 1079-1089 (2012)
47. M.E. Figueroa, O. Abdel-Wahab, C. Lu, P.S. Ward, I. Patel, A. Shih, Y. Li, N. Bhagwat, A. Vasanthakumar, H.F. Fernandez, M.S. Tallman, Z. Sun, K. Wolniak, J.K. Peeters, W. Liu, S.E. Choe, V.R. Fantin, E. Paietta, B. Löwenberg, J.D. Licht, L.A. Godley, R. Delwel, P.J. Valk, C.B. Thompson, R.L. Levine, A. Melnick, Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 18, 553-567 (2010)